Home/Filings/4/0001161697-25-000114
4//SEC Filing

Pazdan Christopher 4

Accession 0001161697-25-000114

CIK 0000704440other

Filed

Mar 20, 8:00 PM ET

Accepted

Mar 21, 4:34 PM ET

Size

14.8 KB

Accession

0001161697-25-000114

Insider Transaction Report

Form 4
Period: 2025-03-17
Pazdan Christopher
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-03-19+36,33184,474 total
  • Exercise/Conversion

    Common Stock

    2025-03-17+5,06349,784 total
  • Tax Payment

    Common Stock

    2025-03-17$2.89/sh1,641$4,73848,143 total
  • Tax Payment

    Common Stock

    2025-03-19$2.83/sh12,849$36,36371,625 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-03-175,06315,192 total
    Common Stock (5,063 underlying)
  • Exercise/Conversion

    Performance Share Unit

    2025-03-1936,3310 total
    Common Stock (36,331 underlying)
Footnotes (5)
  • [F1]Represents settlement of vested performance share units ("PSUs") in shares of the Issuer's common stock.
  • [F2]Represents shares withheld to satisfy tax obligations upon settlement of vested PSUs.
  • [F3]Restricted stock units and performance share units are paid out in shares of common stock on a one-for-one basis.
  • [F4]This restricted stock unit award was granted under the Issuer's 2024 Omnibus Equity Incentive Plan. The units comprising the award vest in equal increments on March 15, 2025 and each first, second and third anniversaries thereof (each, a vesting date). Shares were withheld to satisfy applicable tax withholding obligations.
  • [F5]These performance share units were granted on April 24, 2024. Vesting was dependent upon the achievement by Issuer of certain performance criteria as of December 31, 2024.

Issuer

KORU Medical Systems, Inc.

CIK 0000704440

Entity typeother

Related Parties

1
  • filerCIK 0002028813

Filing Metadata

Form type
4
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 4:34 PM ET
Size
14.8 KB